Skip to content

Propranolol and hemodynamics and sedation

Evaluation of the effect of oral propranolol on hemodynamics and sedation of patients in stereotaxic surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210614051574N1
Enrollment
72
Registered
2021-07-07
Start date
2021-08-10
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor. Malignant neoplasm of brain stem

Interventions

Intervention 1: Intervention group: Patients in this group receive propranolol in a dose of 20 mg, 2 hours before the operation. They will also be anesthetized with fentanyl and midazolam. Interventio

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 20 to 65 years Informed consent to enter the study Candidate for stereotaxic surgery Lack of drug sensitivity

Exclusion criteria

Exclusion criteria: Changing the surgical plan for any reason Changing the anesthesia plan for any reason

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: In minute one, three, five, ten, fifteen after the intervention and at the time of entering the recovery and every fifteen minutes in the recovery. Method of measurement: Measured by barometer.;Sedation. Timepoint: In minute one, three, five, ten, fifteen after the intervention and at the time of entering the recovery and every fifteen minutes in the recovery. Method of measurement: Richmond criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrdad Masoudifar

Esfahan University of Medical Sciences

parsa.alinezhad85@gmail.com+98 31 3668 0042

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026